SOX2 and teratocarcinoma: WX8 reduced the rate of teratocarcinoma formation from injected human ECCs and inhibited the proliferation of undifferentiated Ki67-, OCT4-, and SOX2-positive PSCs within the resulting teratocarcinomas (Chakraborty et al., 2022).